Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PDUFA VI: Innovative Trial Design Proposal Includes Modeling, Simulation

This article was originally published in The Pink Sheet Daily

Executive Summary

Both ideas also will require more FDA expertise, agency tells industry.


Related Content

Trial Simulation, Drug Selection To Be Focus Of US FDA's Drug Development Modeling Pilot
Model-Informed Drug Development: A Risk Firms, Regulators Need To Embrace
PDUFA Negotiations End With Differences To Resolve In Commitment Letter
PDUFA Negotiations End, Approval Process Ongoing
Blizzard Doesn't Stop PDUFA Talks
PDUFA VI: Innovative Trial Design Talks Can’t Have Formal Meeting Goals, FDA Says
FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
FDA Orphan Approval Flexibility Remains Steady As Pressure Increases
PDUFA V: Final Recommendations Fund Proposals In Two Of Three Tiers





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts